Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone Cardiac Effects in T2DM
NCT00300911Phase 4Completed
- Sponsor
- Baskent University
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by Baskent University. Started Dec 2005; status: completed.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00300911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300911.